Active substances
Loratadine + Pseudoephedrine
- SFDA 8
- US FDA 9
- Health Canada 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CLARINASE TAB | 120,5 mg,mg | Tablet · Oral use | 14 Blister | SAR 18.85 | NCE · OTC | BAYER CONSUMER CARE AG | Valid |
| DEFONASE SYRUP | 12,1 mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 21.00 | Generic · OTC | DEEF PHARMACEUTICAL INDUSTRIES | Valid |
| Fedlora | 12,1 mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 17.35 | Generic · OTC | BATTERJEE PHARMACETICAL FACTORY | Valid |
| LORINASE SYRUP | 12,1 mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 22.90 | Generic · OTC | SPIMACO ADDWAEIH | Valid |
| CLARINASE 5MG+60MG-5ML SYRUP | 12,1 mg/ml,mg/ml | Syrup · Oral use | 1 Bottle | SAR 16.05 | Generic · OTC | SCHERING-PLOUGH | Invalid · Not Marketed |
| CLARINASE TAB | 5, 120 mg | Tablet · Oral use | 14 Blister | SAR 21.20 | NCE · OTC | SCHERING-PLOUGH | Withdrawn by MAH · Not Marketed |
| LORA S tablet | 5, 120 mg | Tablet · Oral use | 14 Blister | SAR 13.15 | Generic · OTC | DAMMAM PHARMA | Suspended · Not Marketed |
| LORINASE TABLETS | 5, 120 mg | Tablet · Oral use | 14 Blister | SAR 14.60 | Generic · OTC | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ALLERGIC RHINITIS
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CLARITIN-D | 5MG;120MG | tablet, extended release · oral | BAYER HEALTHCARE LLC | Over-the-counter | 14 Nov 1994 |
| CLARITIN-D 24 HOUR | 10MG;240MG | tablet, extended release · oral | BAYER HEALTHCARE LLC | Over-the-counter | 23 Aug 1996 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 5MG;120MG | tablet, extended release · oral | PERRIGO PHARMA INTL | Over-the-counter | 30 Jan 2003 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | tablet, extended release · oral | P AND L | Over-the-counter | 21 Feb 2003 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | tablet, extended release · oral | PERRIGO PHARMA INTL | Over-the-counter | 4 Mar 2004 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | tablet, extended release · oral | SUN PHARM INDS LTD | Over-the-counter | 22 Sep 2004 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 10MG;240MG | tablet, extended release · oral | BIONPHARMA | Over-the-counter | 14 May 2024 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 5MG;120MG | tablet, extended release · oral | DR REDDYS | Over-the-counter | 6 Aug 2026 |
| LORATADINE AND PSEUDOEPHEDRINE SULFATE | 5MG;120MG | tablet, extended release · oral | HERITAGE PHARMA | Discontinued | 28 Jan 2004 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| CLARITIN ALLERGY + SINUS | 01945157 | 120 MG; 5 MG | TABLET (IMMEDIATE- AND EXTENDED-RELEASE) · ORAL | BAYER INC |
| CLARITIN ALLERGY + SINUS EXTRA STRENGTH | 02260557 | 240 MG; 10 MG | TABLET (IMMEDIATE- AND EXTENDED-RELEASE) · ORAL | BAYER INC |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.